1 min to read News Posted on March 17, 2023 Pear Therapeutics exploring sale, other 'strategic alternatives' – Mobihealth News Pear Therapeutics exploring sale, other ‘strategic alternatives’ Mobihealth News Source: Pear Therapeutics exploring sale, other ‘strategic alternatives’ – Mobihealth News share tweet share 5 things you really should not buy in 2023 – MorningstarSPAC Promoters Lost $1B+ in 2022, and There’s More Pain to Come – 24/7 Wall St.Report: SPACs and De-SPACing: Considerations for Going Public Through a Combination with a SPACWhy Buy a SPAC Before It Identifies a Target? Tags: SPACs